- Home
- LGCL vs CCEL Comparison
LGCL vs CCEL Comparison
Compare LGCL & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- CCEL
- Stock Information
- Founded
- LGCL 2009
- CCEL 1989
- Country
- LGCL China
- CCEL United States
- Employees
- LGCL N/A
- CCEL N/A
- Industry
- LGCL
- CCEL Managed Health Care
- Sector
- LGCL
- CCEL Health Care
- Exchange
- LGCL NYSE
- CCEL Nasdaq
- Market Cap
- LGCL 48.3M
- CCEL 50.0M
- IPO Year
- LGCL 2024
- CCEL 1997
- Fundamental
- Price
- LGCL $0.55
- CCEL $7.47
- Analyst Decision
- LGCL
- CCEL
- Analyst Count
- LGCL 0
- CCEL 0
- Target Price
- LGCL N/A
- CCEL N/A
- AVG Volume (30 Days)
- LGCL 98.9K
- CCEL 13.0K
- Earning Date
- LGCL 11-22-2024
- CCEL 02-26-2025
- Dividend Yield
- LGCL N/A
- CCEL 3.40%
- EPS Growth
- LGCL 11.49
- CCEL N/A
- EPS
- LGCL 0.14
- CCEL N/A
- Revenue
- LGCL $173,306,912.00
- CCEL $31,838,476.00
- Revenue This Year
- LGCL N/A
- CCEL $3.97
- Revenue Next Year
- LGCL N/A
- CCEL $0.91
- P/E Ratio
- LGCL $4.15
- CCEL N/A
- Revenue Growth
- LGCL N/A
- CCEL 1.95
- 52 Week Low
- LGCL $0.47
- CCEL $4.47
- 52 Week High
- LGCL $5.00
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- CCEL 47.98
- Support Level
- LGCL N/A
- CCEL $6.74
- Resistance Level
- LGCL N/A
- CCEL $7.50
- Average True Range (ATR)
- LGCL 0.00
- CCEL 0.38
- MACD
- LGCL 0.00
- CCEL 0.02
- Stochastic Oscillator
- LGCL 0.00
- CCEL 62.39
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.